Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Teladoc Health Inc (TDOC) vs Vistra Corp (VST) Price & Performance

Teladoc Health IncTrade
Vistra CorpTrade

Price performance (Past 24H)

Key statistics

Teladoc Health Inc vs Vistra Corp — how do they compare? Teladoc Health Inc trades at $5.54 (market cap $1.01B), while Vistra Corp trades at $158.64 (market cap $52.41B). The key difference: Vistra Corp is far larger — about 51.9× Teladoc Health Inc's market cap, and Vistra Corp pays a 0.59% dividend while Teladoc Health Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Teladoc Health Inc for 39 Days and Vistra Corp for 32 Days on average.

TDOCVST
Market Cap
$1.01B$52.41B
Volume
4,668,47711,278,074
Sector
HealthUtilities
52-Week High
$9.72$210.85
52-Week Low
$4.47$134.71
Typical Hold Time
39 Days32 Days
Enterprise Value
$1.27B$74.34B
Dividend Yield
—0.59%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Teladoc Health Inc

Teladoc Health (TDOC) trades at $5.56, down 3.64% on the day, reflecting persistent bearish technical signals and negative earnings. The stock shows weak profitability with a net income margin of -7.13% and negative ROE, though valuation ratios like P/S of 0.4 and EV/EBITDA of 5.89 appear low. Recent news includes a CFO transition and ongoing investor investigations, adding to uncertainty.

The outlook remains challenging due to consecutive net losses and competitive pressures, but the consensus price target of $8.83 suggests potential upside if operational improvements materialize. Key risks include sustained unprofitability, high debt levels, and weak sentiment, requiring careful monitoring of cost management and revenue stabilization efforts.

Vistra Corp

Vistra Corp (VST) trades at $166.72, up 3.88% with strong analyst support (91% buy ratings) and a $215.23 consensus target. The stock shows bullish technical momentum above key support at $162, while fundamentals reveal impressive 75.73% ROE and 11.55% net margin. Recent developments include a $4.2 billion US loan for nuclear expansion and a 20-year power deal with New Era Energy, positioning VST to capitalize on AI-driven electricity demand.

Vistra offers compelling exposure to the AI power infrastructure theme with strong profitability and government backing, though investors face earnings volatility risks as seen in recent quarterly misses. The stock trades at a premium valuation (P/E 26.33) but maintains upside potential if execution on nuclear expansion and data center contracts meets expectations.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

TDOC

No sentiment data available yet.

VST
21% Buy79% Sell
Avg holding period · 32 Days

Top news

Latest headlines on both assets

About Teladoc Health Inc

Teladoc Health is a virtual health provider with a telehealth platform delivering 24-hour, on-demand healthcare via mobile devices, the internet, video, and phone. It also offers remote patient monitoring programs for chronic care management. Its platform connects members with a network of physicians and behavioral health professionals. Most of the company's revenue is generated from access fees on a subscription basis (per member, per month). The balance comes from visit fees and equipment rental and sales to hospital systems. Since inception, Teladoc has primarily partnered with employers, health plans, and health systems to offer network access to their members.

Read more on TDOC →

About Vistra Corp

Vistra is a leading integrated retail electricity and power generation company that serves as a critical infrastructure provider for the digital economy. It operates a diversified portfolio of zero-carbon nuclear and renewable assets alongside a massive, flexible natural gas fleet, positioning it as an indispensable partner for energy-intensive AI data centers and industrial electrification.

Read more on VST →